Ushbu ishga iqtibos qilgan ishlar

11 ta ish

Ish: Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

   Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

   MaqolaTuberculosis Research and EpidemiologyEurosurveillance201315 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.163910

2. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study

   Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov +14

   MaqolaTuberculosis Research and EpidemiologyPLoS ONE20154 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000023

3. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Jane Greig +5

   MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 iqtibos

   ABIABI:AkademIndex/openalex/2016.article.000054

4. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

   Parvati Nair, T. Hasan, K. K. Zaw +9

   MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20223 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.281624

5. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

   Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

   MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.000207

6. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

   Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

   MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.262609

7. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms

   Stefan Köhler, Damin Asadov, Andreas Bründer +4

   MaqolaHIV/AIDS Impact and ResponsesThe International Journal of Tuberculosis and Lung Disease20142 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.364601

8. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study

   Tatiana Belkina, Doniyor S Khojiev, Mirzagaleb Tillyashaykhov +4

   MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20141 iqtibos

   ABIABI:AkademIndex/openalex/2014.article.000040

9. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

   MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 iqtibos

   ABIABI:AkademIndex/openalex/2018.article.000181

10. Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?

    Ruzilya Usmanova, Nargiza Parpieva, Hayk Davtyan +6

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.262607

11. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan

    S. Moe, M. L. Rekart, D. Hernandez +9

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20231 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.281628